Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Contents
- Clinical Review Report
- Abbreviations
- Executive Summary
- 1. Introduction
- 2. Objectives and Methods
- 3. Results
- 4. Discussion
- 5. Conclusions
- APPENDIX 1. Patient Input Summary
- APPENDIX 2. Literature Search Strategy
- APPENDIX 3. Excluded Studies
- APPENDIX 4. Detailed Outcome Data
- APPENDIX 5. Validity of Outcome Measures
- Aim
- Findings
- Assessment tools for disease activity: Bath Ankylosing Spondylitis Disease Activity Index
- Validity of BASDAI
- Assessment tools for physical function: Bath Ankylosing Spondylitis Functional Index
- Validity of BASFI
- Assessment tools for spinal mobility: Bath Ankylosing Spondylitis Metrology Index
- Validity of BASMI
- Other instruments and scores for ankylosing spondylitis: Assessment in ankylosing spondylitis – response criteria
- ASAS improvement criteria
- ASAS 20 (symptom-modifying response)
- ASAS partial remission criteria
- Validity and evaluation of ASAS improvement criteria
- Tools for assessment of quality of life in ankylosing spondylitis: ASQoL
- SF-36
- The validity of SF-36
- EQ-5D
- The validity of EQ-5D
- Tools for assessment of radiologic change
- Validity of mSASSS
- Tools for assessment of work productivity: The Rheumatoid Arthritis-Specific Work Productivity Survey
- The validity of WPS-RA
- Conclusions
- APPENDIX 6. Summary of the Extended Phase of Study AS-001
- APPENDIX 7. Summary of Manufacturer-Submitted Mixed Treatment Comparison
- References
- Pharmacoeconomic Review Report
- Patient Group Input Submissions
- CDEC Final Recommendation
- NLM CatalogRelated NLM Catalog Entries
- Impact of Certolizumab Pegol on Patient-Reported Outcomes in Patients With Axial Spondyloarthritis.[Arthritis Care Res (Hoboken). ...]Impact of Certolizumab Pegol on Patient-Reported Outcomes in Patients With Axial Spondyloarthritis.Sieper J, Kivitz A, van Tubergen A, Deodhar A, Coteur G, Woltering F, Landewé R. Arthritis Care Res (Hoboken). 2015 Oct; 67(10):1475-80.
- Efficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: the J-RAPID randomized, placebo-controlled trial.[Mod Rheumatol. 2014]Efficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: the J-RAPID randomized, placebo-controlled trial.Yamamoto K, Takeuchi T, Yamanaka H, Ishiguro N, Tanaka Y, Eguchi K, Watanabe A, Origasa H, Shoji T, Sakamaki Y, et al. Mod Rheumatol. 2014 Sep; 24(5):715-24. Epub 2013 Dec 9.
- Review Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis.[Health Technol Assess. 2010]Review Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis.Connock M, Tubeuf S, Malottki K, Uthman A, Round J, Bayliss S, Meads C, Moore D. Health Technol Assess. 2010 Oct; 14(Suppl. 2):1-10.
- Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population.[Arthritis Res Ther. 2015]Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population.Weinblatt ME, Fleischmann R, van Vollenhoven RF, Emery P, Huizinga TW, Cutolo M, van der Heijde D, Duncan B, Davies O, Luijtens K, et al. Arthritis Res Ther. 2015 Nov 15; 17:325. Epub 2015 Nov 15.
- Review Certolizumab pegol for the management of Crohn's disease in adults.[Clin Ther. 2009]Review Certolizumab pegol for the management of Crohn's disease in adults.Rivkin A. Clin Ther. 2009 Jun; 31(6):1158-76.
- Certolizumab Pegol (Cimzia)Certolizumab Pegol (Cimzia)
Your browsing activity is empty.
Activity recording is turned off.
See more...